If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes
Get Live Data
1.30    0.00 (0.00%)
Bid:
1.25
Ask:
1.35
Spread: 0.10 (8.00%)
Market Cap: £20.87m
GDR Live PriceLast checked at - London Stock Exchange

Intraday Genedrive Share Chart

Block Listing Returns

31 May 2023 07:00

RNS Number : 0413B
Genedrive PLC
31 May 2023
 

 

genedrive plc

("genedrive" or the "Company")

 

Block Listing Returns

 

The Company confirms the block listing six monthly return for the period to 31 May 2023.

 

Name of applicant

genedrive plc

 

Name of scheme

2007 Share Option Scheme

 

Period of return:

From:

01 December 2022

To:

 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

139,226 shares

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

7,500 shares

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

131,726 shares

 

 

In order to co-terminate future block listing returns the Company confirms the following returns for the two block listings granted earlier in the month.

 

Name of applicant

genedrive plc

 

Name of scheme

2017 Share Option Scheme

 

Period of return:

From:

19 May 2023

To:

 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

1,150,588 shares

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,150,588 shares

 

 

Name of applicant

genedrive plc

 

Name of scheme

Unapproved Share Option Scheme

 

Period of return:

From:

19 May 2023

To:

 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

2,668,144 shares

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

2,668,144 shares

 

Name of contact:

Russ Shaw CFO

Telephone number of contact:

+44 (0)161 989 0245

 

For enquires:

 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Russ Shaw: CFO

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Duckworth

finnCap (Joint Broker)

+44 (0)20 7220 500

Geoff Nash / George Dollemore / Nigel Birks / Alice Lane

Walbrook PR Ltd (Media Relations & Investor Relations)

+44 (0)20 7933 8780 or genedrive@walbrookpr.com

Paul McManus / Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRFLFILETIIVIV
Date   Source Headline
10th Jun 20099:50 amRNSHolding(s) in Company
30th Mar 20093:22 pmRNSDirector Declaration
17th Mar 20095:08 pmRNSAdditional Listing
11th Mar 20097:04 amRNSHalf Yearly Report
2nd Mar 20097:00 amRNSRe Agreement
24th Feb 200911:22 amRNSNotice of Results
5th Dec 20087:30 amRNSAnnual Report and Accounts
28th Nov 20087:30 amRNSChange of Nomad and Adviser
10th Nov 20087:30 amRNSChange of Nomad and Adviser
13th Oct 20088:54 amRNSIssue of Equity & TVR
8th Oct 20083:19 pmRNSChange of Adviser Name
6th Oct 20087:00 amRNSPreliminary Results - October 2008
1st Sep 20087:30 amRNSEPISTEM AND ROTTAPHARM ANNOUN
31st Jul 200811:06 amRNSTrading Update
24th Jul 20088:54 amRNSEPISTEM ANNOUNCE COLLABORATIO
23rd Jun 20087:00 amRNSMASCC Conference
7th Apr 20087:01 amRNSData to be Released at AACR
1st Apr 200810:31 amRNSEpistem services for EBI
5th Mar 20084:31 pmRNSSenior Management Appointment
28th Feb 20087:30 amRNSInterim Results
12th Feb 200811:57 amRNSNotice of Results
30th Nov 20074:23 pmRNSTotal Voting Rights
28th Nov 20072:17 pmRNSAGM Statement
20th Nov 20073:32 pmRNSIssue of Equity
2nd Nov 20078:56 amRNSNotifiable Interest
2nd Nov 20078:41 amRNSNotice of AGM
23rd Oct 200710:15 amRNSDirector/PDMR Shareholding
10th Oct 20077:01 amRNSPreliminary Results
20th Sep 20077:01 amRNSResearch Update
17th Aug 20079:57 amRNSAIM Rule 26
31st Jul 20077:01 amRNSTrading Update
28th Jun 20072:16 pmRNSDirectors Shareholdings
22nd May 20077:30 amRNSResearch Update
4th Apr 20078:00 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.